Drug profile · INN
darunavir and cobicistat
PREZCOBIX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
darunavir and cobicistat (PREZCOBIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN darunavir and cobicistat
Brand PREZCOBIX
Route ORAL
Formulation TABLET, FOR SUSPENSION
Frequently asked questions
What is darunavir and cobicistat?
darunavir and cobicistat (PREZCOBIX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for darunavir and cobicistat?
PREZCOBIX is a marketed brand name for darunavir and cobicistat. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of darunavir and cobicistat?
darunavir and cobicistat has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.